HEXIM1
Protein HEXIM1
Also known as: CLP-1, EDG1, HEXI1_HUMAN, HIS1, MAQ1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O94992
- Gene
- HEXIM1
- Ensembl
- ENSG00000186834
- Chromosome
- 17
- Canonical length
- 359 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Expression of this gene is induced by hexamethylene-bis-acetamide in vascular smooth muscle cells. This gene has no introns. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
359 residues, UniProt reviewed canonical sequence.
>O94992|HEXIM1
1 MAEPFLSEYQ HQPQTSNCTG AAAVQEELNP ERPPGAEERV PEEDSRWQSR AFPQLGGRPG
61 PEGEGSLESQ PPPLQTQACP ESSCLREGEK GQNGDDSSAG GDFPPPAEVE PTPEAELLAQ
121 PCHDSEASKL GAPAAGGEEE WGQQQRQLGK KKHRRRPSKK KRHWKPYYKL TWEEKKKFDE
181 KQSLRASRIR AEMFAKGQPV APYNTTQFLM DDHDQEEPDL KTGLYSKRAA AKSDDTSDDD
241 FMEEGGEEDG GSDGMGGDGS EFLQRDFSET YERYHTESLQ NMSKQELIKE YLELEKCLSR
301 MEDENNRLRL ESKRLGGDDA RVRELELELD RLRAENLQLL TENELHRQQE RAPLSKFGDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HEXIM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 34 nTPM
- skeletal muscle: 31 nTPM
- adrenal gland: 31 nTPM
- blood vessel: 30 nTPM
- liver: 26 nTPM
- spleen: 24 nTPM
Single-cell type
- syncytiotrophoblasts: 594 nCPM
- megakaryocytes: 315 nCPM
- epididymal basal cells: 291 nCPM
- breast myoepithelial cells: 270 nCPM
- tuft cells: 254 nCPM
- colonocytes: 212 nCPM
Immune cell
- basophil: 16 nTPM
- neutrophil: 10 nTPM
- non-classical monocyte: 7.3 nTPM
- eosinophil: 6.8 nTPM
- intermediate monocyte: 6.1 nTPM
- gdT-cell: 4.2 nTPM
Brain region
- thalamus: 46 nTPM
- midbrain: 44 nTPM
- spinal cord: 41 nTPM
- medulla oblongata: 39 nTPM
- choroid plexus: 38 nTPM
- hypothalamus: 38 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 1.41
- DepMap mean gene effect
- -0.35
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of innate immune response
- heart development
- innate immune response
- negative regulation of transcription by RNA polymerase II
- negative regulation of transcription elongation by RNA polymerase II
- negative regulation of viral transcription
- positive regulation of signal transduction by p53 class mediator
Molecular functions
- 7SK snRNA binding
- cyclin-dependent protein serine/threonine kinase inhibitor activity
- identical protein binding
- P-TEFb complex binding
- protein kinase inhibitor activity
- snRNA binding
- transcription regulator inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HEXIM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HEXIM1 as an antibody target. Whether an autoantibody or antibody against HEXIM1 could matter depends on whether native HEXIM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HEXIM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HEXIM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...